Published in Clin Exp Immunol on March 01, 1978
Total and allergen-specific IgE in relation to allergic response pattern following bone marrow transplantation. Clin Exp Immunol (1986) 0.86
Increased serum IgE concentrations during infection and graft versus host disease after bone marrow transplantation. J Clin Pathol (1984) 0.85
The in vitro effect of the thymic factor thymopoietin on a subpopulation of lymphocytes from severely malnourished children. Clin Exp Immunol (1980) 0.81
E rosetting lymphocytes in inflammatory bowel disease. An analysis using monoclonal antibodies. Clin Exp Immunol (1983) 0.77
Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med (1972) 24.43
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
Transient IgA deficiency and pathogenesis of infantile atopy. Lancet (1973) 4.07
Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet (1967) 3.63
Regulation of homocytotropic antibody formation in the rat. VI. Inhibitory effect of thymocytes on the homocytotropic antibody response. J Immunol (1971) 3.48
Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc Natl Acad Sci U S A (1970) 2.89
IgE concentrations in children with atopic diseases. A clinical study. Int Arch Allergy Appl Immunol (1969) 2.84
Regulation of homocytotropic antibody formation in the rat. 3. Effect of thymectomy and splenectomy. J Immunol (1971) 2.61
Rosette-forming cells, immunologic deficiency diseases and transfer factor. N Engl J Med (1973) 2.02
Evaluation of T-cells and thymic serum factors in man using the rosette technique. Transplant Rev (1973) 1.87
Immunoglobulin deficiencies in an atopic population. Lancet (1970) 1.69
Thymosin activity in patients with cellular immunodeficiency. N Engl J Med (1975) 1.67
Regulation of homocytotropic antibody formation in the rat. 8. An antigen-specific T cell factor that regulates anti-hapten homocytotropic antibody response. J Immunol (1973) 1.61
Serum IgD and IgE concentrations in immunodeficiency diseases. J Clin Invest (1975) 1.57
Thymus-derived rosette-forming cells. N Engl J Med (1973) 1.50
Regulation of antibody response in vitro. VII. Enhancing soluble factors for IgG and IgE antibody response. J Immunol (1973) 1.41
Depression of cell-mediated immunity in atopic eczema. J Allergy Clin Immunol (1975) 1.37
Thymus dependence of reaginic antibody formation in mice. J Immunol (1973) 1.19
IgE levels in sera of children with asthma. Pediatrics (1971) 1.15
Allergic contact sensitivity in atopic dermatitis. Arch Dermatol (1973) 1.13
Immunological capabilities of patients with atopic dermatitis. J Invest Dermatol (1966) 1.11
Regulation of homocytotropic antibody formation in the rat. IV. Effects of various immunosuppressive drugs. J Immunol (1971) 1.10
PPD and mitogen responsiveness of lymphocytes from patients with atopic dermatitis. Clin Exp Immunol (1977) 1.08
Humoral and cellular immunity in asthma. J Allergy Clin Immunol (1975) 1.08
T and B lymphocytes in atopic eczema. Arch Dermatol (1974) 1.03
Suppressed cell-mediated immunity in two adults with atopic dermatitis. Br J Dermatol (1972) 1.03
Effect of immunosuppressive therapy for renal allografts on the number of circulating sheep red blood cells rosetting cells. Transplantation (1975) 1.02
IgE in immunodeficiency. Am J Pathol (1972) 0.95
Thymic alymphoplasia with hyper-IgE-globulinemia. Pediatrics (1973) 0.92
IgE in allergic diseases. Proc R Soc Med (1969) 0.88
Wiskott-Aldrich syndrome with 18-year survival. Treatment with transfer factor. Am J Dis Child (1975) 0.87
Provoking factors in asthma. Br J Dis Chest (1971) 0.86
Asthma and T cell immunodeficiency: improvement with transfer factor and immunopeptide. Ann Allergy (1976) 0.83
Eosinophil and allergy. Nihon Ketsueki Gakkai Zasshi (1973) 0.82
B and T cells in dermatitis. Mayo Clin Proc (1974) 0.81
IgG, IgA and IgM by formylated rocket immunoelectrophoresis. Ann Clin Biochem (1975) 0.80
Lymphocyte subpopulations, serum IgE and total eosinophil counts in patients with bronchial asthma. Clin Exp Immunol (1975) 0.80
Studies on interrelations between eosinophilia, serum IgE and tissue mast cells. Clin Allergy (1975) 0.78
T and B lymphocyte rosettes in bronchial asthma. Ann Allergy (1976) 0.78
The nature and significance of sheep red blood cell rosettes. Ann Allergy (1975) 0.77
Study of E rosettes, serum IgE and eosinophilia in asthmatic children. Ann Allergy (1976) 0.77
A study of serum immunoglobulins including IgE and reaginic antibodies in patients with bronchial asthma in relation to the spectrum of the disease. Clin Allergy (1975) 0.77
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol (1999) 8.96
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol (1999) 8.92
"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int (1998) 3.53
Serum gamma-G-globulin levels and gestational age in premature babies. Lancet (1967) 3.37
Development and validation of a mood measure for adolescents. J Sports Sci (1999) 3.13
Relatives of probands: models for preliminary genetic analysis. Ann Hum Genet (1971) 2.92
Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell Immunol (1973) 2.81
Paraproteins, benign or malignant? Br Med J (1967) 2.80
Immune imbalance in dysgammaglobulinaemia type IV. Lancet (1968) 2.74
Immunochemical studies on the serum, intestinal secretions and intestinal mucosa in patients with adult celiac disease and other forms of the celiac syndrome. Gastroenterology (1970) 2.66
Ocular blood flow velocity in age-related macular degeneration. Ophthalmology (1995) 2.53
Lymphocyte abnormality in chronic mucocutaneous candidiasis. Lancet (1970) 2.38
Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet (1981) 2.22
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet (1993) 2.09
Early diagnosis of brain death in patients treated with central nervous system depressant drugs. Transplantation (2000) 2.07
Complement metabolism in rheumatoid arthritis. I. Longitudinal studies. Ann Rheum Dis (1973) 2.04
Immunoglobulins in clinical chemistry. Adv Clin Chem (1971) 2.03
Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol (1995) 1.98
Six cases of gamma-D myelomatosis. Lancet (1966) 1.92
Gamma-M deficiency predisposing to meningococcal septicaemia. Br Med J (1967) 1.88
Serum-gamma-G-globulin levels in normal premature, post-mature, and "small-for-dates" newborn babies. Lancet (1968) 1.85
Secondary antibody deficiency. Proc R Soc Med (1968) 1.84
Immunochemical classes of myelomatosis. Including data from a therapeutic trial conducted by a Medical Research Council working party. Br J Haematol (1969) 1.83
Prolactin dependence in human breast cancers. Lancet (1972) 1.82
Standardisation of the mixed lymphocyte reaction. J Immunol Methods (1976) 1.77
Five cases of alpha chain disease. Gut (1972) 1.75
Immunocytoma o' mice an' men. Br Med J (1971) 1.74
Immunoglobulin deficiencies in an atopic population. Lancet (1970) 1.69
In-vitro oestrogen sensitivity of breast-cancer tissue as a possible screening method for hormonal treatment. Lancet (1972) 1.69
Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J Immunol (1989) 1.67
New oncofetal antigen for human pancreas. Lancet (1974) 1.66
Growth rates and responses to treatment in human myelomatosis. Br J Haematol (1969) 1.57
Immunological mystery of coeliac disease. Lancet (1969) 1.56
A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol (2000) 1.53
Detection of antibodies which can cooperate with lymphocytes. Lancet (1972) 1.51
Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage. Biochem J (1986) 1.51
Treatment of "primary" renal amyloidosis with melphalan. Lancet (1972) 1.51
Immunological studies on the mechanism of gold hypersensitivity reactions. Br Med J (1973) 1.50
Laboratory investigation of paraproteinaemia. J Clin Pathol (1988) 1.50
Uncomplicated HL-A matched sibling bone marrow graft for combined immune deficiency. Br Med J (1972) 1.49
Group B Streptococcal sacroiliitis: case report and review. Scand J Infect Dis (2001) 1.47
Disturbances of the immunoglobulins. Sci Basis Med Annu Rev (1966) 1.43
Selection of hormone-dependent breast cancers. Br J Surg (1974) 1.42
A staining method for proteins and dextrans on cellulose acetate. Nature (1965) 1.40
Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity, and susceptibility to inhibition. J Immunol (2000) 1.38
Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients. Br Med J (Clin Res Ed) (1982) 1.35
Optimal selectin-mediated rolling of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression. Proc Natl Acad Sci U S A (1998) 1.33
Coeliac disease, vasculitis, and cryoglobulinaemia. Gut (1972) 1.31
Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor. Clin Exp Immunol (1972) 1.31
Paraproteins. Proc R Soc Med (1969) 1.31
Tyrosine phosphorylation of CD22 during B cell activation. Science (1992) 1.29
The immunoglobulins in Hodgkin's disease. Immunology (1967) 1.28
An evaluation of the Hyland laser nephelometer PDQ system for the measurement of immunoglobulins. Ann Clin Biochem (1978) 1.28
Standardization of lymphocyte transformation to Candida immunogen. Clin Exp Immunol (1974) 1.25
Role of mosquitoes in transmission of hepatitis B antigen. J Infect Dis (1973) 1.24
Are some women's breast cancers androgen dependent? Lancet (1973) 1.21
Development and initial validation of an instrument to assess the motivational qualities of music in exercise and sport: the Brunel Music Rating Inventory. J Sports Sci (1999) 1.20
The P-selectin glycoprotein ligand-1 is important for recruitment of neutrophils into inflamed mouse peritoneum. Blood (1997) 1.19
Urinary isoamylases in the diagnosis of chronic pancreatitis. Gut (1967) 1.18
Turnover of proteoglycans in cultures of bovine articular cartilage. Arch Biochem Biophys (1984) 1.17
Mite-contaminated foods as a cause of anaphylaxis. J Allergy Clin Immunol (1997) 1.16
Serum proteins in liver disease. Proc R Soc Med (1967) 1.15
Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization. J Cell Biol (1988) 1.14
Bone marrow suppression by antilymphocytic globulin. Br Med J (1975) 1.14
Assay of circulating immunoglobulins in patients with fibrosing alveolitis. Clin Exp Immunol (1967) 1.14
Dysgammaglobulinaemia type IV C. Clin Exp Immunol (1967) 1.14
Bone marrow transplantation for severe aplastic anaemia. A review of the Westminster experience of 24 cases. Clin Lab Haematol (1983) 1.14
Anxiety, self-confidence and performance in Tae Kwon-Do. Percept Mot Skills (1997) 1.13
Rocket immunoselection for detection of heavy-chain diseases. Clin Chem (1974) 1.13
Behaviours caregivers use to determine pain in non-verbal, cognitively impaired individuals. Dev Med Child Neurol (1998) 1.12
Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency. J Clin Invest (1999) 1.11
Immmunosuppressive drugs in the treatment of autoimmune haemolytic anaemia. Proc R Soc Med (1968) 1.11
IgM paraproteins. J Clin Pathol Suppl (Assoc Clin Pathol) (1975) 1.11
Schizophrenia: evidence for the major gene hypothesis. Behav Genet (1970) 1.10
Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period. J Clin Pathol (1984) 1.10
Clinical significance of 7s IgM in monoclonal IgM diseases. Br Med J (1971) 1.09
Impaired IgA responses in coeliac disease. Lancet (1971) 1.09
Immunoglobulins in chronic cold haemagglutinin disease. Br J Haematol (1970) 1.08
Preparation of a calibration material for specific protein assay (SPS-01). Ann Clin Biochem (1984) 1.08
A discrete subpopulation of human monocytes expresses a neutrophil-like proinflammatory (P) phenotype. Am J Physiol (1994) 1.08
Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol (1998) 1.08
Do judges enhance home advantage in European championship boxing? J Sports Sci (2005) 1.07
The serum paraprotein level related to the number of plasmacytoma-5536 cells in C3H mice. Br J Cancer (1970) 1.07
Timing of cyclosporin-A therapy for abrogation of HVG and GVH responses in rats. Lancet (1979) 1.07
Diminished mixed lymphocyte reaction in ankylosing spondylitis, relatives, and normal individuals all with HL-A 27. Ann Rheum Dis (1976) 1.07
Non-immunoglobulin-bearing 'B' lymphocytes in chronic lymphatic leukaemia? Br J Haematol (1973) 1.06
A half-molecule GK plasmacytoma. Clin Exp Immunol (1969) 1.06
Psychological predictors of injury among elite athletes. Br J Sports Med (2005) 1.05
Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology (1999) 1.05
Immune status in atopic eczema: a survey. Br J Dermatol (1979) 1.05
Heavy chain typing in IgG monoclonal gammopathies with special reference to cases of serum hyperviscosity and cryoglobulinaemia. Clin Exp Immunol (1971) 1.05
Immunoglobulins in warm-type autoimmune haemolytic anaemia. Lancet (1969) 1.04
A comparison of elderly participants in a community survey with nonparticipants. Public Health Rep (1991) 1.04
7S anti-tumour antibodies and activated Fc in macrophage tumour cell interaction. Eur J Cancer (1973) 1.03
Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G. J Immunol (1995) 1.00
Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: Late post-transplant period. J Clin Pathol (1984) 1.00